Heidelberg Engineering’s donation will support the delivery of four live webinars on our award winning telemedicine platform Cybersight, on topics including optical coherence tomography (OCT), a non-invasive imaging test that uses light to take 3D cross-section images of the back of the eye. An OCT test helps to spot serious eye conditions such as glaucoma, age-related macular degeneration and diabetic retinopathy.
Heidelberg Engineering
High-tech imaging solutions company, Heidelberg Engineering, have committed €80,000 to support our work improving vision services by funding crucial teaching opportunities and research.
The company’s generous funding will also allow us to continue our research project into retinoblastoma, an eye cancer, which affects 9,000 children worldwide each year. 92% of children diagnosed live in low-and-middle-income countries where late diagnosis, limited accessibility to eye care, and lack of treatment-specific resources contributes to a 40% survival rate within three years of diagnosis.
The project, which will also utilise Cybersight, will investigate the impact of artificial intelligence on worldwide retinoblastoma care. It will also look at how treatment, outcomes and disease-specific knowledge continues to change over time.
Partnership
Imaging is a critical tool that enables eye health professionals around the world to provide early detection for eye conditions. As a global leader in imaging and healthcare technology, Heidelberg Engineering’s expertise in the development of these tools, such as OCT, and our focus on education, creates a strong partnership through which we can support eye care teams to fully utilise their diagnostic equipment.
If you would like to learn about ways your company could support Orbis and our sight saving work, please email:
Email address: [email protected]
